当前位置：
X-MOL 学术
›
Cancer Discov.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Trastuzumab Deruxtecan Is Effective in HER2-Low Breast Cancer.
Cancer Discovery ( IF 29.7 ) Pub Date : 2020-04-01 , DOI: 10.1158/2159-8290.cd-rw2020-030 American Association for Cancer Research
Cancer Discovery ( IF 29.7 ) Pub Date : 2020-04-01 , DOI: 10.1158/2159-8290.cd-rw2020-030 American Association for Cancer Research
The anti-HER2-drug conjugate trastuzumab deruxtecan (T-DXd) was effective in HER2-low breast cancer.
中文翻译：
曲妥珠单抗Deruxtecan对HER2低度乳腺癌有效。
抗HER2药物偶联物曲妥珠单抗德鲁替康（T-DXd）对HER2低的乳腺癌有效。
更新日期：2020-04-01
中文翻译：
曲妥珠单抗Deruxtecan对HER2低度乳腺癌有效。
抗HER2药物偶联物曲妥珠单抗德鲁替康（T-DXd）对HER2低的乳腺癌有效。
京公网安备 11010802027423号